Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-08-22 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2021年限制性股票激励计划授予价格、授予及归属数量调整相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the adjustment of the grant price, grant quantity, and vesting quantity related to the 2021 restricted stock incentive plan of Shenzhen Huitai Medical Devices Co., Ltd. It references various approvals by the board, supervisory committee, independent directors, and shareholders' meetings, as well as compliance with relevant laws and regulations. The document is focused on legal compliance and authorization of stock incentive plan adjustments rather than financial results, earnings, or general corporate governance changes. It is not a full annual or interim report, nor an earnings release or call transcript. It is a detailed legal opinion on a specific stock incentive plan adjustment, which fits best under the category of Regulatory Filings (RNS) as it is a compliance/legal document that does not fit other categories like Remuneration Information or Board/Management Information. The document length is over 10,000 characters and contains substantive content, so it is not a mere announcement or report publication notice.
2024-08-22 Chinese
2024年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2024年半年度募集资金存放与实际使用情况的专项报告" which translates to "2024 Semi-Annual Special Report on the Deposit and Actual Use of Raised Funds." It details the use and management of funds raised from a public stock issuance, including specific amounts, bank accounts, investment products, and compliance with regulatory requirements. The document references the China Securities Regulatory Commission and includes detailed financial data about the use of raised capital for the half-year period ending June 30, 2024. This is a specialized report focused on the management and use of capital raised through financing activities, not a general financial report or earnings release. It is not an announcement of a report but contains substantive financial data and analysis related to capital usage. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-08-22 Chinese
关于调整2021年限制性股票激励计划授予价格、授予及归属数量的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding adjustments to the 2021 restricted stock incentive plan of Shenzhen Huitai Medical Devices Co., Ltd. It details the board and supervisory meetings approving changes to the grant price, grant quantity, and vesting quantity of restricted stock. The document includes legal opinions, meeting resolutions, and detailed explanations of the adjustments. It is not a full annual report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement. The content focuses on changes to stock incentive plans, which is a form of remuneration information related to executive and employee compensation. Therefore, the document fits best under the category of Remuneration Information (DEF 14A). The document length and detail confirm it is the actual announcement, not just a publication notice or regulatory filing.
2024-08-22 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2024 半年度报告摘要' which translates to '2024 Half-Year Report Summary'. It contains detailed financial data such as total assets, net profit, earnings per share, and shareholder information for the half-year period. The document length is over 6,000 characters, indicating substantive content rather than a brief announcement. It explicitly states it is a half-year report summary, which aligns with an Interim / Quarterly Report. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-22 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2024 年半年度报告" which translates to "2024 Semi-Annual Report". It contains detailed financial data, management discussion and analysis, company overview, business segments, core technologies, and other comprehensive information typical of a half-year financial report. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes actual financial statements and substantive financial data for the period January 1 to June 30, 2024. The presence of management discussion and analysis further supports classification as an Interim / Quarterly Report. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2024
2024-08-22 Chinese
公司章程
Governance Information Classification · 100% confidence The document is a detailed corporate charter or articles of association for Shenzhen Huitai Medical Devices Co., Ltd. It includes chapters on company general provisions, business scope, share issuance, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, financial accounting system, profit distribution, audit, notices and announcements, mergers, amendments to the charter, and other corporate governance matters. It references laws and regulations such as the Company Law, Securities Law, and listing rules of the Shanghai Stock Exchange Sci-Tech Innovation Board. The content is focused on the company's internal governance structure, shareholder rights, board responsibilities, and procedural rules for meetings and resolutions. There is no financial performance data, earnings information, or audit report content. The document is not an announcement or a brief summary but a full governance document. Therefore, it fits the category of Governance Information (CGR).
2024-08-22 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.